— Know what they know.
Not Investment Advice
Also trades as: VIMTALABS.BO (BSE) · $vol 0M

VIMTALABS.NS NSE

Vimta Labs Limited
1W: -2.2% 1M: -11.7% 3M: -0.2% YTD: +25.2% 1Y: -11.4% 3Y: +157.8% 5Y: +273.9%
₹590.00 ($6.13)
-10.30 (-1.72%)
 
NSE · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 41 · ₹26.4B mcap · 14M float · 2.71% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₹26.4B ($273.8M)
52W Range376.05-774.7
Volume118,310
Avg Volume385,011
Beta-0.18
Dividend₹2.00
Analyst Ratings
No analyst coverage
Company Info
CEOHarita Vasireddi
Employees1,384
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2005-12-15
Websitevimta.com
Plot Nos. 141/2 & 142, IDA, Phase II
Hyderabad, TS 500051
IN
91 40 2726 4141
About Vimta Labs Limited

Vimta Labs Limited provides specialized contract research and analytical testing services, operating both within India and internationally. Their extensive offerings encompass general laboratory analyses, comprehensive food and water quality testing, support for preclinical and clinical research, detailed structural and functional assessments of biological molecules, environmental impact studies, and clinical diagnostic reference laboratory capabilities. The company serves a wide array of industries, including pharmaceuticals, biopharmaceuticals, food production, consumer goods, electronics, electrical equipment, agrochemicals, healthcare, medical devices, and many more. Established in 1984, Vimta Labs Limited is headquartered in Hyderabad, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms